Abstract
Fenoldopam mesylate is a useful antihypertensive and diuretic drug. In this review, we examine the evidence based medicine wheter to use fenoldopam in cardiac surgery patients and/or in critically ill patients with or at risk for acute renal failure (ARF). We conclude that from published studies it seems that fenoldopam could be beneficial if a prolonged infusion is performed starting early in the process of ARF in critically ill patients. Unfortunately there is still virtually no definitive evidence of efficacy, especially in cardiac surgery patients. A large, multicenter, randomized, controlled trial (RCT) is needed to confirm the promising but conflicting findings of this drug.
Translated title of the contribution | Fenoldopamin in cardiac surgery |
---|---|
Original language | German |
Journal | Clinical Research in Cardiology Supplements |
Volume | 2 |
Issue number | SUPL.1 |
DOIs | |
Publication status | Published - 2007 |
Keywords
- acute renal failure
- cardiac surgery
- diuretics
- fenoldopam
- renal replacement therapy
ASJC Scopus subject areas
- Molecular Biology
- Radiology Nuclear Medicine and imaging
- Structural Biology